Ferring Pharmaceuticals, originally founded in Sweden in 1950, are the leading experts behind Euflexxa. The research driven company behind the Euflexxa brand, now has manufacturing facilities spread globally in Argentina, China, Czech Republic, Mexico, Scotland, Switzerland, to name a few and its corporate headquarters in Switzerland.
With 5000 employees worldwide, therapeutic areas include reproductive health, gastroenterology, orthopedics and urology. A vast market researcher in the global pharmaceutical market trade, Ferring continue to research and develop in their R&D centres in China, Denmark, India, Israel, Japan, Scotland, Switzerland and USA.
Filler World stock Euflexxa, the 1% sodium hyaluronate that is known to be ultra pure.